Medtech Insight is honoring May and June awareness months for mental health, Alzheimer’s and brain health by speaking with industry leaders about rising innovations to address neurological diseases and mental health, the regulatory and investment climate, reimbursement, and more.
Forty percent to 50% of depression patients will not respond to the first treatment prescribed to them, and most treatments require at least two weeks to assess response, often amounting to a